Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

European urology oncology

Showing results (1-10 of 993) with videos related to

Pageof 100
Sort By:
European Urology Oncology|December 8, 2020
Utility of Serum miR-371a-3p in Predicting Relapse on Surveillance in Patients with Clinical Stage I Testicular Germ Cell CancerJoão Lobo, Ricardo Leão, Ad J M Gillis, et al.
European Urology Oncology|November 25, 2022
Positive Prostate-specific Membrane Antigen Findings: How To Interpret ThemKelsey L Pomykala, Ken Herrmann, Elisabetta Lalumera, et al.
European Urology Oncology|June 17, 2022
Selecting the Best Candidates for Cisplatin-based Adjuvant Chemotherapy After Radical Cystectomy Among Patients with pN+ Bladder CancerLuca Afferi, Chiara Lonati, Francesco Montorsi, et al.
European Urology Oncology|June 19, 2022
Intermediate-risk Non-muscle-invasive Bladder Cancer: Updated Consensus Definition and Management Recommendations from the International Bladder Cancer GroupWei Shen Tan, Gary Steinberg, J Alfred Witjes, et al.
European Urology Oncology|July 19, 2022
The Surgical Learning Curve for Biochemical Recurrence After Robot-assisted Radical ProstatectomyCarlo A Bravi, Paolo Dell'Oglio, Elio Mazzone, et al.
European Urology Oncology|July 22, 2019
Treatment Facility Volume and Survival in Patients with Advanced Prostate CancerShreyas S Joshi, Elizabeth R Handorf, Danielle Sienko, et al.
European Urology Oncology|July 15, 2019
Stereotactic ablative radiation therapy for oligometastatic renal cell carcinoma (SABR ORCA): a meta-analysis of 28 studiesNicholas G Zaorsky, Eric J Lehrer, Gargi Kothari, et al.
European Urology Oncology|April 19, 2024
Prognostic Significance of Immune Cell Infiltration in Muscle-invasive Bladder Cancer Treated with Definitive Chemoradiation: A Secondary Analysis of RTOG 0524 and RTOG 0712Zaker Rana, Sophia C Kamran, Amol C Shetty, et al.
European Urology Oncology|September 28, 2019
Progression-directed Therapy for Oligoprogression in Castration-refractory Prostate CancerCharlien Berghen, Steven Joniau, Piet Ost, et al.
European Urology Oncology|September 29, 2019
Effect of Antibiotic Use on Outcomes with Systemic Therapies in Metastatic Renal Cell CarcinomaAly-Khan A Lalani, Wanling Xie, David A Braun, et al.
Pageof 100

Showing results (1-10 of 993) with videos related to

Sort By:
Pageof 100
European Urology Oncology|December 8, 2020
Utility of Serum miR-371a-3p in Predicting Relapse on Surveillance in Patients with Clinical Stage I Testicular Germ Cell CancerJoão Lobo, Ricardo Leão, Ad J M Gillis, et al.
European Urology Oncology|November 25, 2022
Positive Prostate-specific Membrane Antigen Findings: How To Interpret ThemKelsey L Pomykala, Ken Herrmann, Elisabetta Lalumera, et al.
European Urology Oncology|June 17, 2022
Selecting the Best Candidates for Cisplatin-based Adjuvant Chemotherapy After Radical Cystectomy Among Patients with pN+ Bladder CancerLuca Afferi, Chiara Lonati, Francesco Montorsi, et al.
European Urology Oncology|June 19, 2022
Intermediate-risk Non-muscle-invasive Bladder Cancer: Updated Consensus Definition and Management Recommendations from the International Bladder Cancer GroupWei Shen Tan, Gary Steinberg, J Alfred Witjes, et al.
European Urology Oncology|July 19, 2022
The Surgical Learning Curve for Biochemical Recurrence After Robot-assisted Radical ProstatectomyCarlo A Bravi, Paolo Dell'Oglio, Elio Mazzone, et al.
European Urology Oncology|July 22, 2019
Treatment Facility Volume and Survival in Patients with Advanced Prostate CancerShreyas S Joshi, Elizabeth R Handorf, Danielle Sienko, et al.
European Urology Oncology|July 15, 2019
Stereotactic ablative radiation therapy for oligometastatic renal cell carcinoma (SABR ORCA): a meta-analysis of 28 studiesNicholas G Zaorsky, Eric J Lehrer, Gargi Kothari, et al.
European Urology Oncology|April 19, 2024
Prognostic Significance of Immune Cell Infiltration in Muscle-invasive Bladder Cancer Treated with Definitive Chemoradiation: A Secondary Analysis of RTOG 0524 and RTOG 0712Zaker Rana, Sophia C Kamran, Amol C Shetty, et al.
European Urology Oncology|September 28, 2019
Progression-directed Therapy for Oligoprogression in Castration-refractory Prostate CancerCharlien Berghen, Steven Joniau, Piet Ost, et al.
European Urology Oncology|September 29, 2019
Effect of Antibiotic Use on Outcomes with Systemic Therapies in Metastatic Renal Cell CarcinomaAly-Khan A Lalani, Wanling Xie, David A Braun, et al.
Pageof 100